Moorthy L N, Baldino M E, Kurra V, Puwar D, Llanos A, Peterson M G E, Hassett A L, Lehman T J A
1 Rutgers-Robert Wood Johnson Medical School, New Brunswick, USA.
2 Rutgers School of Public Health, Piscataway, USA.
Lupus. 2017 Mar;26(3):255-265. doi: 10.1177/0961203316659546. Epub 2016 Aug 19.
Previously, we described associations between health-related quality of life (HRQOL) and disease-related factors among childhood onset systemic lupus erythematosus (cSLE) patients. Here we determined the relationship between HRQOL, disease activity and damage in a large prospective international cohort of cSLE. We compared HRQOL, disease activity and disease damage across different continents and examined the relationship between children's and parents' assessments of HRQOL. Patients with cSLE and their parents completed HRQOL measures at enrollment and ≥4 follow-up visits. Physicians assessed disease activity and damage. The multinational cohort ( n = 467) had relatively low disease activity and damage. Patient and parent HRQOL scores were significantly correlated. Asian and European patients had the highest HRQOL, while South and North American patients had lower HRQOL scores. Renal, CNS, skin and musculoskeletal systems exhibited the highest levels of damage. North and South American and Asian patients were more likely to have disease damage and activity scores above median values, compared with Europeans. Asians were more likely to use cyclophosphamide/rituximab. Female gender, high disease activity and damage, non-White ethnicity, and use of cyclophosphamide and/rituximab were related to lower HRQOL. HRQOL domain scores continue to emphasize that SLE has widespread impact on all aspects of children's and parents' lives.
此前,我们描述了儿童期起病的系统性红斑狼疮(cSLE)患者健康相关生活质量(HRQOL)与疾病相关因素之间的关联。在此,我们在一个大型前瞻性国际cSLE队列中确定了HRQOL、疾病活动度和损伤之间的关系。我们比较了不同大洲的HRQOL、疾病活动度和疾病损伤情况,并研究了儿童与父母对HRQOL评估之间的关系。cSLE患者及其父母在入组时和≥4次随访时完成了HRQOL测量。医生评估了疾病活动度和损伤情况。该多国队列(n = 467)的疾病活动度和损伤程度相对较低。患者和父母的HRQOL评分显著相关。亚洲和欧洲患者的HRQOL最高,而南美洲和北美洲患者的HRQOL评分较低。肾脏、中枢神经系统、皮肤和肌肉骨骼系统的损伤程度最高。与欧洲人相比,南美洲和北美洲以及亚洲患者更有可能出现疾病损伤且活动评分高于中位数。亚洲人更有可能使用环磷酰胺/利妥昔单抗。女性、高疾病活动度和损伤、非白人种族以及使用环磷酰胺和/或利妥昔单抗与较低的HRQOL相关。HRQOL领域评分继续强调SLE对儿童和父母生活的各个方面都有广泛影响。